Epidiolex Archives - CDR – Chain Drug Review

Cannabis-based product rules continue to vary

August 15, 2019 by Shannon Cox and Stephen Cummings 2018 Farm Bill, cannabis, Epidiolex, Food and Drug Administration August 12, 2019, Opinion

There is a growing public focus on the potential for legitimate pharmacological uses of cannabis. Much of this focus has been directed toward medical marijuana — the use of marijuana in plant form or its basic extracts. Although some states have legalized its use, the Food and Drug Administration has not approved marijuana in plant

FDA approves first marijuana-based prescription drug

June 26, 2018 by Chain Drug Review Epidiolex, Lennox-Gastaut syndrome and Dravet syndrome, medical marijuana, or CBD, purified cannabidiol, U.S. Food and Drug Administration Leading Headlines, Pharmacy

WASHINGTON — The U.S. Food and Drug Administration has approved a marijuana-derived drug for the treatment of two rare and serious forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, that begin in childhood but can persist in adulthood. The drug is made from purified cannabidiol (CBD), a compound found in the cannabis plant. The drug